Researchers have developed an optical biopsy system that can distinguish between cancerous and healthy liver tissue. The new technology could make it easier to diagnose liver cancer, which is the sixth most common cancer ...
Jan 6, 2022
0
159
Clinicians, scientists from the National Cancer Center Singapore (NCCS) and institutional collaborators have described a dynamic genomic landscape of tumor heterogeneity in hepatocellular carcinoma (HCC). This research comes ...
Dec 13, 2021
0
7
In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach. It is based on using humanized antibodies called immune checkpoint inhibitors (ICIs) to block the cellular pathways ...
Dec 7, 2021
0
56
A UC Davis Health team has developed a first-of-its-kind positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in patients affected with non-alcoholic fatty liver disease.
Nov 30, 2021
0
34
A research team with the Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Sciences reported their discovery that a metabolic regulation mechanism may play a role in malignant transformation of non-alcoholic ...
Nov 29, 2021
0
11
In 2015, University of Alberta cancer researcher Jack Tuszynski learned that his patent application for a promising chemotherapy treatment for people suffering from metastatic bladder cancer had been rejected by the U.S. ...
Nov 23, 2021
0
5
There are still no established biomarkers to predict the success of immunotherapy in patients with liver cancer. In a multicentre study led by Matthias Pinter from the Division of Gastroenterology and Hepatology of the Medical ...
Nov 22, 2021
0
5
(HealthDay)—Elevated serum iron and transferrin saturation levels are significantly associated with an increased risk for developing liver cancer in patients with nonalcoholic fatty liver disease (NAFLD), according to a ...
Nov 16, 2021
0
2
A Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric weight loss surgery significantly lowered their future risk of liver disease complications and serious cardiovascular ...
Nov 11, 2021
0
5
In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.
Nov 9, 2021
0
53
